Abstract
Background
Data from the Shanghai Breast Cancer Study were analyzed to evaluate the relationship between benign breast disease (BBD) and breast cancer among Chinese women with a self-report of physician-diagnosed BBD.
Methods
Study participants consisted of 3,452 breast cancer cases and 3,474 population controls recruited by the Shanghai Breast Cancer Study. In-person interviews were conducted to collect information on demographics and suspected risk factors for breast cancer, including a detailed history of BBD. Unconditional logistic regression was used to derive adjusted odds ratios (ORadj) and 95% confidence intervals (CI) for the association between self-reported BBD and breast cancer.
Results
Women with breast cancer were significantly more likely to have a self-reported history of BBD including lobular proliferation (ORadj = 1.6; 95% CI 1.4–1.8), fibroadenoma (ORadj = 1.9; 95% CI 1.6–2.3), and other BBD (ORadj = 1.6; 95% CI 1.3–2.1). Breast cancer risk was lower for surgically treated fibroadenoma as compared to non-surgically treated and higher for other BBDs that were surgically treated versus non-surgically treated.
Conclusions
Our results suggest that personal history of BBD is associated with an increased risk of future breast cancer among women in China. Surgical intervention for fibroadenoma may reduce the risk.
Similar content being viewed by others
References
Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA (2005) Global trends in breast cancer incidence and mortality 1973–1997. Int J Epidemiol 34:405–412
Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74–108
Gao YT, Shu XO, Dai Q et al (2000) Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai breast cancer study. Int J Cancer 87:295–300
Marchant DJ (2002) Benign breast disease. Obstet Gynecol Clin North Am 29:1–20
Santen RJ, Mansel R (2005) Benign breast disorders. N Engl J Med 353:275–285
Hartmann LC, Sellers TA, Frost MH et al (2005) Benign breast disease and the risk of breast cancer. N Engl J Med 353:229–237
Aiello EJ, Buist DS, White E, Seger D, Taplin SH (2004) Rate of breast cancer diagnoses among postmenopausal women with self-reported breast symptoms. J Am Board Fam Pract 17:408–415
Page DL, Jensen RA, Simpson JF, Dupont WD (2000) Historical and epidemiologic background of human premalignant breast disease. J Mammary Gland Biol Neoplasia 5:341–349
Fitzgibbons PL, Henson DE, Hutter RV (1998) Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer committee of the college of American pathologists. Arch Pathol Lab Med 122:1053–1055
Wang J, Costantino JP, Tan-Chiu E, Wickerham DL, Paik S, Wolmark N (2004) Lower-category benign breast disease and the risk of invasive breast cancer. J Natl Cancer Inst 96:616–620
Dupont WD, Parl FF, Hartmann WH et al (1993) Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258–1265
Marshall LM, Hunter DJ, Connolly JL et al (1997) Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6:297–301
Hughes LE, Mansel RE, Webster DJ (1987) Aberrations of normal development and involution (ANDI): a new perspective on pathogenesis and nomenclature of benign breast disorders. Lancet 2:1316–1319
Cheng J, Qiu S, Raju U, Wolman SR, Worsham MJ (2007) Benign breast disease heterogeneity: association with histopathology, age, and ethnicity. Breast Cancer Res Treat [Epub ahead of print 2007 Oct 5]
Bodian CA, Perzin KH, Lattes R, Hoffmann P (1993) Reproducibility and validity of pathologic classifications of benign breast disease and implications for clinical applications. Cancer 71:3908–3913
Cook MG, Rohan TE (1985) The patho-epidemiology of benign proliferative epithelial disorders of the female breast. J Pathol 146:1–15
Courtillot C, Plu-Bureau, Binart N et al (2005) Benign breast diseases. J Mammary Gland Biol Neoplasia 10:325–335
Geneva Foundation for Medical Education and Research (2008) WHO collaborating centre in education and research in human reproduction
World Health Organization (1968) Histological Typing of Breast Tumors. WHO Geneva
Worsham MJ, Raju U, Lu M, Kapke A, Cheng J, Wolman SR (2007) Multiplicity of benign breast lesions is a risk factor for progression to breast cancer. Clin Cancer Res 13:5474–5479
Anonymous (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363:157–163
Hislop TG, Elwood JM (1981) Risk factors for benign breast disease: a 30-year cohort study. Can Med Assoc J 124:283–291
Webb PM, Byrne C, Schnitt SJ et al (2002) Family history of breast cancer, age and benign breast disease. Int J Cancer 100:375–378
Wu C, Ray RM, Lin MG et al (2004) A case–control study of risk factors for fibrocystic breast conditions: Shanghai nutrition and breast disease study, China, 1995–2000. Am J Epidemiol 160:945–960
Charreau I, Plu-Bureau, Bachelot A, Contesso G, Guinebretiere JM, Le MG (1993) Oral contraceptive use and risk of benign breast disease in a French case–control study of young women. Eur J Cancer Prev 2:147–154
Lubin JH, Brinton LA, Blot WJ, Burns PE, Lees AW, Fraumeni JF Jr (1983) Interactions between benign breast disease and other risk factors for breast cancer. J Chronic Dis 36:525–531
Dupont WD, Page DL, Parl FF et al (1994) Long-term risk of breast cancer in women with fibroadenoma. N Engl J Med 331:10–15
El-Wakeel H, Umpleby HC (2003) Systematic review of fibroadenoma as a risk factor for breast cancer. Breast 12:302–307
LiVolsi VA, Stadel BV, Kelsey JL, Holford TR (1979) Fibroadenoma in oral contraceptive users: a histopathologic evaluation of epithelial atypia. Cancer 44:1778–1781
Shabtai M, Saavedra-Malinger P, Shabtai EL et al (2001) Fibroadenoma of the breast: analysis of associated pathological entities—a different risk marker in different age groups for concurrent breast cancer. Isr Med Assoc J 3:813–817
Roberts MM, Jones V, Elton RA, Fortt RW, Williams S, Gravelle IH (1984) Risk of breast cancer in women with history of benign disease of the breast. Br Med J (Clin Res Ed) 288:275–278
Yu H, Rohan TE, Cook MG, Howe GR, Miller AB (1992) Risk factors for fibroadenoma: a case–control study in Australia. Am J Epidemiol 135:247–258
Gateley CA, Bundred NJ, West RR, Mansel RE (1992) A case–control study of factors associated with macroscopic breast cysts. Eur J Cancer 28:125–127
Mauvais-Jarvis P, Kuttenn F, Gompel A (1986) Antiestrogen action of progesterone in breast tissue. Breast Cancer Res Treat 8:179–188
London SJ, Connolly JL, Schnitt SJ, Colditz GA (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941–944
Dixon JM, McDonald C, Elton RA, Miller WR (1999) Risk of breast cancer in women with palpable breast cysts: a prospective study. Edinburgh Breast Group. Lancet 353:1742–1745
Ory H, Cole P, MacMahon B, Hoover R (1976) Oral contraceptives and reduced risk of benign breast diseases. N Engl J Med 294:419–422
Clavel F, Benhamou E, Sitruk-Ware R, Mauvais-Jarvis P, Flamant R (1985) Breast cancer and oral contraceptives: a review. Contraception 32:553–569
Budai B, Szamel I, Sulyok Z et al (2000) Influence of hormonal status of patients with cystic disease on the composition of cyst fluid and breast cancer risk. Anticancer Res 20:3879–3886
Goehring C, Morabia A (1997) Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 19:310–327
Pike MC, Spicer DV, Dahmoush L, Press MF (1993) Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 15:17–35
Marchant DJ (2002) Inflammation of the breast. Obstet Gynecol Clin North Am 29:89–102
Zagorianakou P, Zagorianakou N, Stefanou D, Makrydimas G, Agnantis NJ (2006) The enigmatic nature of apocrine breast lesions. Virchows Arch 448:525–531
Anderson BO, Braun S, Carlson RW et al (2003) Overview of breast health care guidelines for countries with limited resources. Breast J 9(Suppl 2):S42–S50
Gupta RK, McHutchison AG, Dowle CS, Simpson JS (1993) Fine-needle aspiration cytodiagnosis of breast masses in pregnant and lactating women and its impact on management. Diagn Cytopathol 9:156–159
Scott-Conner CE, Schorr SJ (1995) The diagnosis and management of breast problems during pregnancy and lactation. Am J Surg 170:401–405
Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR (2004) A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 159:308–317
Clegg LX, Potosky AL, Harlan LC et al (2001) Comparison of self-reported initial treatment with medical records: results from the prostate cancer outcomes study. Am J Epidemiol 154:582–587
Haapanen N, Miilunpalo S, Pasanen M, Oja P, Vuori I (1997) Agreement between questionnaire data and medical records of chronic diseases in middle-aged and elderly Finnish men and women. Am J Epidemiol 145:762–769
Iversen L, Hannaford PC, Godden DJ, Price D (2007) Do people self-reporting information about chronic respiratory disease have corroborative evidence in their general practice medical records? A study of intermethod reliability. Prim Care Respir J 16:162–168
Madlensky L, McLaughlin J, Goel V (2003) A comparison of self-reported colorectal cancer screening with medical records. Cancer Epidemiol Biomarkers Prev 12:656–659
Maunsell E, Drolet M, Ouhoummane N, Robert J (2005) Breast cancer survivors accurately reported key treatment and prognostic characteristics. J Clin Epidemiol 58:364–369
Puleo E, Zapka JG, Goins KV et al (2005) Recommendations for care related to follow-up of abnormal cancer screening tests: accuracy of patient report. Eval Health Prof 28:310–327
Canfell K, Beral V, Green J, Cameron R, Baker K, Brown A (2006) The agreement between self-reported cervical smear abnormalities and screening programme records. J Med Screen 13:72–75
Naughton-Collins M, Barry MJ, Caubet JF et al (2004) Validity of primary care patient self-report of abnormal (but not cancer) prostate biopsy results. J Urol 172:2366–2368
Acknowledgments
This research was supported by grant R01 CA64277 from the National Cancer Institute, USA. The authors would like to thank research team of the Shanghai Cancer Institute for their support in conducting this study. We also thank Bethanie Hull who provided assistance with the preparation of this manuscript.
Author information
Authors and Affiliations
Corresponding author
Appendix I
Appendix I
Categories of the College of American Pathologists classification of benign breast disease [9,10]
Pathologic category | Level of increased risk for invasive breast cancer | Pathological types included in the category |
---|---|---|
1 | No increase | Adenosis (other than sclerosing adenosis) |
Ductal ectasia | ||
Fibroadenoma without complex features | ||
Fibrosis | ||
Mastitis | ||
Mild hyperplasia without atypia | ||
Ordinary cysts (gross or microscopic) | ||
Simple apocrine metaplasia (no associated hyperplasia or adenosis) | ||
Squamous metaplasia | ||
2 | Slightly increased | Fibroadenoma with complex features |
Moderate or florid hyperplasia without atypia | ||
Sclerosing adenosis, | ||
Solitary papilloma without coexistent atypical hyperplasia | ||
3 | Moderately increased | Atypical ductal hyperplasia |
Atypical lobular hyperplasia | ||
4 | Markedly increased | Ductal carcinoma in situ |
Lobular carcinoma in situ |
Rights and permissions
About this article
Cite this article
Dorjgochoo, T., Deming, S.L., Gao, YT. et al. History of benign breast disease and risk of breast cancer among women in China: a case–control study. Cancer Causes Control 19, 819–828 (2008). https://doi.org/10.1007/s10552-008-9145-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-008-9145-6